Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Epigenetics · United Kingdom · 2025-08-01

Processing Time
58 days
Decision Date
2025-08-01
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in epigenetics, specifically focusing on the molecular mechanisms of carcinogenesis in colon and lung cancers. She utilizes next-generation sequencing to identify DNA methylation markers that serve as early indicators of cancer recurrence or as novel therapeutic targets.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer diagnostics and treatment, which is a pressing public health burden and the second leading cause of death in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of 10 publications and 221 citations, with work appearing in top-tier journals like Nature Communications.

3 Waiver Benefit to the U.S. Met

On balance, the petitioner's contributions to cancer genomics and early detection strategies justify waiving the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 10 peer-reviewed journal articles in high-impact journals like Nature Communications and PNAS, which garnered 221 citations. Her work ranks in the top 10-20% of most-cited articles in her category, satisfying the Dhanasar prongs for being well-positioned and having national importance.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions

Similar Cases

Research Scientist

Biotechnology · Germany

WeGreened EB-2 (NIW) approved
Connecticut 29 days 2023-07-19
The petitioner proposes to continue research into the structural basis of epigenetic modifiers to develop innovative therapeutic interventions for genetic disorders. This work involves the biochemical and structural characterization of recombinant proteins to better understand gene regulation and disease mechanisms. The endeavor aims to advance precision medicine through the development of diagnostic tools for conditions associated with abnormal DNA methylation patterns.
View Case

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Statistician

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 53 days 2025-03-04
The petitioner proposes to continue her research on developing and applying advanced statistical and machine learning models for analyzing multi-omics data. This work aims to advance the development of mRNA cancer immunotherapies for treating melanoma, non-small cell lung cancer, and other solid cancers.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
103 days 2024-02-02
The petitioner proposes to lead oncology projects focusing on organoid platforms and high-throughput screening to identify new immuno-oncology drug candidates. Her work utilizes three-dimensional organoid models and epigenetic profiling to investigate mechanisms of stemness in cancer stem cells and the role of necroptosis in disease progression. The goal is to identify therapeutic targets that curb tumor growth and enhance immune responses for personalized cancer medicine.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from United Kingdom

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 58 days
Criteria Met 3 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in United Kingdom All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist